Nicholas Hornstein/X
Jan 28, 2025, 08:52
Nicholas Hornstein: Resected Gallbladder adenocarcinoma adjuvant chemotherapy vs chemoRT
Nicholas Hornstein, Assistant Professor of Medical Oncology at Northwell Health, shared a post on X:
“ACCELERATE (great name, negative trial)
Resected Gallbladder adenocarcinoma
adjuvant chemotherapy vs chemoRT
No change in outcomes between chemo (GemCis/GemOx) vs Chemo + RT
45 vs 48 patients. Important work!
CA19-9 prognostic.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 28, 2025, 08:52
Jan 28, 2025, 08:49
Jan 28, 2025, 08:46
Jan 28, 2025, 08:45
Jan 28, 2025, 08:44
Jan 28, 2025, 08:41
Jan 28, 2025, 08:35
Jan 28, 2025, 08:32
Jan 28, 2025, 08:32